AlkermesvsUnitedHealth

ALKS and UNH stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$389.68

Value $354B

-5.42%
UNH's page

Alkermes (ALKS) has a market value of $7.6B and UnitedHealth (UNH) $354B. Over the last year, with dividends, ALKS moved +56.5% and UNH +24.3%. Dividend yield: ALKS none, UNH 2.32%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ALKS$7.6B

    UNH$354B

    UNH is 47 times ALKS

  • Revenue, 12 months

    ALKS$1.8B

    UNH$450B

    UNH is 256 times ALKS

  • Net income, 12 months

    ALKS-$351.0K

    UNH$15.9B

  • Operating margin

    ALKS3.7%

    UNH5.3%

    1.6 points apart

  • ROIC

    ALKS1.8%

    UNH11.3%

    9.5 points apart

  • P/E

    ALKS–

    UNH22.3

  • Dividend yield

    ALKS0.0%

    UNH2.3%

    2.3 points apart

  • 5-year return

    ALKS+92.5%

    UNH-5.1%

    97.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ALKS+92.5%

UNH-5.1%

5010015020020222023202420252026
Returns by period
PeriodALKSWith dividendsUNHWith dividends
1 year since November 14, 2025+56.5%Price +56.5%+24.3%Price +21.1%
3 years since November 17, 2023+87.5%+23.3% a yearPrice +87.5%-22.6%-8.2% a yearPrice -27.3%
5 years since November 16, 2021+92.5%+14.0% a yearPrice +92.5%-5.1%-1.0% a yearPrice -13.3%
10 years since November 17, 2016-23.6%-2.7% a yearPrice -23.6%+205.2%+11.8% a yearPrice +158.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ALKSAlkermesUNHUnitedHealth

Valuation

ALKSUNH
Valuation
Price$45.45$389.68
Market value$7.6B$354B
Enterprise value (EV)$8.3B$399B
P/E–22.3
P/E, 5-year median13.325.0
P/B4.13.4
EV/EBIT129.516.7
Free cash flow yield3.0%6.5%

Results and growth

ALKSUNH
Results and growth
Revenue, 12 months$1.8B$450B
Net income, 12 months-$351.0K$15.9B
Free cash flow, 12 months$227M$22.8B
Earnings per share, 12 months-$0.02$17.52
Revenue growth, year on year-5.3%11.8%
Revenue growth a year, past+7.3%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

ALKSUNH
Margins and returns on capital
Gross margin82.9%88.3%
Operating margin3.7%5.3%
Net margin-0.0%3.5%
ROIC1.8%11.3%
ROE-0.0%15.5%

Balance sheet

ALKSUNH
Balance sheet
Cash$755M$28.5B
Total debt$1.6B$74.3B
Net debt / EBITDA8.11.6
Interest cover0.7×6.2×

Dividends and buybacks

ALKSUNH
Dividends and buybacks
Dividend yield–2.3%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.6%
Shareholder yield–3.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ALKS or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Alkermes or UnitedHealth?

By market value, UnitedHealth ($354B) is about 46.7 times Alkermes ($7.6B), at today's prices.

How did ALKS and UNH stock do over the last 10 years?

Since November 17, 2016, ALKS's price moved -23.6% and UNH's +158.5%. With dividends: ALKS -23.6% (-2.7% a year), UNH +205.2% (+11.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, ALKS or UNH?

The dividend yield at today's price is none for Alkermes and 2.32% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, Alkermes or UnitedHealth?

Over the last twelve months, the net margin was -0.0% for Alkermes and 3.5% for UnitedHealth, and the operating margin 3.7% and 5.3%. Revenue was $1.8B and $450B.

Which is the better investment, Alkermes or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.